# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001453687-24-000076
Filing Date
2024-04-26
Accepted
2024-04-26 09:09:18
Documents
15
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | rnac-20240426.htm iXBRL | DEF 14A | 1095068
3 |  | rnac-20240426_g1.jpg | GRAPHIC | 9435
4 |  | rnac-20240426_g2.jpg | GRAPHIC | 226351
5 |  | rnac-20240426_g3.jpg | GRAPHIC | 465914
6 |  | rnac-20240426_g4.jpg | GRAPHIC | 255964
| Complete submission text file | 0001453687-24-000076.txt |  | 3957456

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | rnac-20240426.xsd | EX-101.SCH | 950
18 | EXTRACTED XBRL INSTANCE DOCUMENT | rnac-20240426_htm.xml | XML | 137779

Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37798 | Film No.: 24879126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)